Roger Jeffs Sells 25,000 Shares of Liquidia (NASDAQ:LQDA) Stock

Liquidia Corporation (NASDAQ:LQDA) CEO Roger Jeffs sold 25,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 26th. The stock was sold at an average price of $60.38, for a total transaction of $1,509,500.00. Following the sale, the chief executive officer owned 1,048,095 shares of the company’s stock, valued at approximately $63,283,976.10. This represents a 2.33% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Roger Jeffs also recently made the following trade(s):

• On Thursday, May 21st, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $61.13, for a total transaction of $1,528,250.00.
• On Tuesday, May 19th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $58.65, for a total transaction of $1,466,250.00.
• On Friday, May 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $57.04, for a total transaction of $1,426,000.00.
• On Wednesday, May 13th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $56.29, for a total transaction of $1,407,250.00.
• On Monday, May 11th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $41.50, for a total transaction of $1,037,500.00.
• On Thursday, May 7th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $42.09, for a total transaction of $1,052,250.00.
• On Tuesday, May 5th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $40.10, for a total transaction of $1,002,500.00.
• On Friday, April 17th, Roger Jeffs sold 18,839 shares of Liquidia stock. The stock was sold at an average price of $40.60, for a total transaction of $764,863.40.
• On Wednesday, April 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $40.14, for a total transaction of $1,003,500.00.
• On Tuesday, April 14th, Roger Jeffs sold 3,300 shares of Liquidia stock. The shares were sold at an average price of $40.00, for a total transaction of $132,000.00.

Liquidia Price Performance

NASDAQ LQDA opened at $62.03 on Thursday. The company has a quick ratio of 2.03, a current ratio of 2.22 and a debt-to-equity ratio of 1.18. The stock has a market capitalization of $5.52 billion, a PE ratio of 443.10 and a beta of 0.41. The company has a 50 day moving average price of $43.52 and a two-hundred day moving average price of $38.05. Liquidia Corporation has a 12-month low of $11.85 and a 12-month high of $63.46.

Liquidia (NASDAQ:LQDA) last posted its earnings results on Monday, May 11th. The company reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.41 by $0.11. The firm had revenue of $132.87 million during the quarter, compared to analysts’ expectations of $119.44 million. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. The firm’s revenue for the quarter was up 4187.1% compared to the same quarter last year. As a group, equities analysts predict that Liquidia Corporation will post 2.97 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Liquidia

A number of institutional investors have recently modified their holdings of the company. Covestor Ltd raised its position in shares of Liquidia by 41.9% in the fourth quarter. Covestor Ltd now owns 1,216 shares of the company’s stock valued at $42,000 after purchasing an additional 359 shares during the period. PNC Financial Services Group Inc. raised its position in shares of Liquidia by 7.2% in the fourth quarter. PNC Financial Services Group Inc. now owns 6,304 shares of the company’s stock valued at $217,000 after purchasing an additional 422 shares during the period. Quantinno Capital Management LP raised its position in shares of Liquidia by 3.6% in the first quarter. Quantinno Capital Management LP now owns 17,165 shares of the company’s stock valued at $648,000 after purchasing an additional 589 shares during the period. Northwestern Mutual Wealth Management Co. bought a new position in shares of Liquidia in the fourth quarter valued at approximately $25,000. Finally, ProShare Advisors LLC raised its position in shares of Liquidia by 7.1% in the fourth quarter. ProShare Advisors LLC now owns 11,756 shares of the company’s stock valued at $405,000 after purchasing an additional 775 shares during the period. Institutional investors own 64.54% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on LQDA. Wells Fargo & Company lifted their target price on shares of Liquidia from $51.00 to $62.00 and gave the company an “overweight” rating in a research note on Tuesday, May 12th. Needham & Company LLC lifted their target price on shares of Liquidia from $54.00 to $70.00 and gave the company a “buy” rating in a research note on Monday, May 11th. Zacks Research upgraded shares of Liquidia from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 5th. Lifesci Capital raised shares of Liquidia to a “strong-buy” rating in a research report on Thursday, March 5th. Finally, Jefferies Financial Group reissued a “buy” rating and issued a $60.00 price target on shares of Liquidia in a research report on Monday, May 11th. Three research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $50.88.

More Liquidia News

Here are the key news stories impacting Liquidia this week:

• Positive Sentiment: Liquidia announced that CEO Roger Jeffs and CFO/COO Michael Kaseta will present a business update at the 2026 Jefferies Global Healthcare Conference on June 3, which can help keep investor attention on the company and its growth story. Article Title
• Positive Sentiment: Analysts continue to view Liquidia favorably, with the stock carrying a “Moderate Buy” consensus and several firms recently lifting price targets or upgrading ratings, which supports the rally. Article Title
• Neutral Sentiment: Insider filings showed CEO Roger Jeffs and Director Raman Singh sold shares in recent days, including a 25,000-share sale by the CEO under a pre-arranged 10b5-1 plan; while these trades can raise caution, the sales were disclosed and do not necessarily signal a change in operating outlook. Article Title

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).